+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Enzyme Immunoassay Market Size, Share & Trends Analysis Report by Product (Reagents & Kits, Software & Services), Application (Oncology, Cardiology), Specimen, End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 120 Pages
  • May 2024
  • Region: Global
  • Grand View Research
  • ID: 5976434
Description Jump to:
The global enzyme immunoassay market size is anticipated to reach USD 22.42 billion by 2030, expanding at a CAGR of 3.9% from 2024 to 2030. Increasing prevalence of chronic and infectious diseases, rising demand for point-of-care testing, and growing awareness and healthcare expenditure are expected to boost the market further. Moreover, the increasing number of joint ventures, product launches amongst market players and rising government investment is also expected to have a positive impact on market growth. For instance, in July 2023, Anbio Biotechnology Limited launched the AF-100S FIA Solution, a handheld solution for point-of-care immunodiagnostics. This analyzer can detect a broad spectrum of analyte enzymes and perform up to 240 tests per hour.

Rising government investment is expected to significantly support the market growth of enzyme immunoassay technologies. Government investments aid in the expansion of healthcare infrastructure, primarily in developing countries. This expansion helps in the wider adoption and integration of EIA technologies in clinical settings, enhancing the capacity for early disease detection, monitoring, and management. It also facilitates the establishment of national health programs that can use EIAs for large-scale screening and surveillance activities, such as infectious disease control and prevention programs. For instance, in March 2022, the UK government announced an investment of USD 347 million to enhance research and development and the production of novel devices and diagnostics.

The COVID-19 pandemic had a significant impact on the market. The pandemic caused disturbances in the supply chain and manufacturing processes of various healthcare products, including EIA kits and reagents. These disruptions were due to lockdown measures, labor shortages, and logistical challenges. However, the pandemic impacted the market by accelerating the development and adoption of EIA technologies for the detection of SARS-CoV-2 antibodies. This surge in demand was driven by the need for mass testing to identify infected individuals and understand the spread of the virus. Enzyme immunoassays, known for their specificity and sensitivity, became vital tools in the fight against the pandemic, used for diagnosing active infections and studies to assess the extent of virus spread within populations.

The development and optimization of EIAs require significant expertise in both the biological and engineering aspects of the technology. Ensuring high specificity and sensitivity can be challenging, especially for novel or rapidly mutating targets. Obtaining regulatory approval for new assays is a lengthy and expensive process. Regulatory standards can vary significantly between different regions, complicating the global distribution and use of these assays.

Enzyme Immunoassay Market Report Highlights

  • Based on product, the reagents and kits segment dominated the market with a share of 67.5% in 2023. The growth is attributed to the rising prevalence of infectious and autoimmune diseases
  • Based on application, the infectious diseases segment dominated the market in 2023 and is expected to grow at the fastest CAGR over the forecast period
  • Based on specimen, the blood specimen segment dominated the market in 2023. The urine specimen segment is anticipated to grow at the fastest CAGR over the forecast period
  • Based on end-use, the hospitals segment dominated the market in 2023
  • North America dominated the enzyme immunoassay market in 2023 owing to factors such as the high purchasing power parity, government support for quality healthcare, and availability of reimbursement

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. Application
1.2.3. Speicmen
1.2.4. End-use
1.3. Information Analysis
1.4. Market Formulation & Data Visualization
1.5. Data Validation & Publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Incidence of Chronic and Infectious Diseases
3.2.1.2. Increasing Demand for Point-of-care Diagnostics
3.2.1.3. Growing Demand for Portable and Automated Immunoassays
3.2.2. Market Restraint Analysis
3.2.2.1. Lower Detection Limit
3.2.2.2. Limitations Associated with Immunoassay Techniques
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Enzyme Immunoassay Market: Product Business Analysis
4.1. Segment Dashboard
4.2. Global Enzyme Immunoassay Market Product Movement Analysis
4.3. Global Enzyme Immunoassay Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Reagents & Kits
4.4.1. Global Reagents & Kits Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Analyzers/Instruments
4.5.1. Global Analyzers/Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Software & Services
4.6.1. Global Software & Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Enzyme Immunoassay Market: Application Business Analysis
5.1. Segment Dashboard
5.2. Global Enzyme Immunoassay Market Application, Movement Analysis
5.3. Global Enzyme Immunoassay Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Therapeutic Drug Monitoring
5.4.1. Global Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Oncology
5.5.1. Global Oncology Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Cardiology
5.6.1. Global Cardiology Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Endocrinology
5.7.1. Global Endocrinology Market Estimates and Forecasts, 2018-2030 (USD Million)
5.8. Infectious Disease Testing
5.8.1. Global Infectious Disease Testing Market Estimates and Forecasts, 2018-2030 (USD Million)
5.9. Autoimmune Diseases
5.9.1. Global Autoimmune Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
5.10. Others
5.10.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Enzyme Immunoassay Market: Specimen Business Analysis
6.1. Segment Dashboard
6.2. Global Enzyme Immunoassay Market Specimen Movement Analysis
6.3. Global Enzyme Immunoassay Market Size & Trend Analysis, by Specimen, 2018 to 2030 (USD Million)
6.4. Blood
6.4.1. Global Blood Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Saliva
6.5.1. Global Saliva Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Urine
6.6.1. Global Urine Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7. Other Specimens
6.7.1. Global Other Specimens Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Enzyme Immunoassay Market: End-use Business Analysis
7.1. Segment Dashboard
7.2. Global Enzyme Immunoassay Market End-use Movement Analysis
7.3. Global Enzyme Immunoassay Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
7.4. Hospitals
7.4.1. Global Hospitals Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Blood Banks
7.5.1. Global Blood Banks Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Clinical Laboratories
7.6.1. Global Clinical Laboratories Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7. Pharmaceutical and Biotech Companies
7.7.1. Global Pharmaceutical and Biotech Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8. Academic Research Centers
7.8.1. Global Academic Research Centers Market Estimates and Forecasts, 2018-2030 (USD Million)
7.9. Others
7.9.1. Global Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. Enzyme Immunoassay Market: Regional Estimates & Trend Analysis by Product, Application, Specimen & End-use
8.1. Regional Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
8.3. North America
8.3.1. North America Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.2. U.S.
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. U.S. Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.3. Canada
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Canada Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4. Europe
8.4.1. Europe Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.2. UK
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. UK Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.3. Germany
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Germany Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.4. France
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. France Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.5. Italy
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Italy Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.6. Spain
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Spain Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.7. Denmark
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Denmark Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.8. Sweden
8.4.8.1. Key Country Dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Regulatory Framework
8.4.8.4. Sweden Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.9. Norway
8.4.9.1. Key Country Dynamics
8.4.9.2. Competitive Scenario
8.4.9.3. Regulatory Framework
8.4.9.4. Norway Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5. Asia-Pacific
8.5.1. Asia-Pacific Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.2. Japan
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Japan Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.3. China
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. China Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.4. India
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. India Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.5. Australia
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Australia Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.6. Thailand
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Thailand Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.7. South Korea
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. South Korea Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6. Latin America
8.6.1. Latin America Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.2. Brazil
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Brazil Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.3. Mexico
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Mexico Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.4. Argentina
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Argentina Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7. MEA
8.7.1. MEA Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.2. South Africa
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. South Africa Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.3. Saudi Arabia
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Saudi Arabia Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.4. UAE
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. UAE Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.5. Kuwait
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. Kuwait Enzyme Immunoassay Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2023
9.4. Participant’s Overview
9.4.1. Siemens Healthineers
9.4.1.1. Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Danaher Corporation (Beckman Coulter)
9.4.2.1. Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. BioMérieux SA
9.4.3.1. Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Sysmex Corporation
9.4.4.1. Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. QuidelOrtho Corporation.
9.4.5.1. Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Bio-Rad Laboratories, Inc.
9.4.6.1. Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. F. Hoffmann-La Roche AG
9.4.7.1. Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Becton, Dickinson, and Company
9.4.8.1. Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Thermo Fisher Scientific, Inc.
9.4.9.1. Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 4 Global Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 5 Global Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 6 Global Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 7 Global Enzyme Immunoassay Market, by Region, 2018-2030 (USD Million)
Table 8 North America Enzyme Immunoassay Market, by Country, 2018-2030 (USD Million)
Table 9 North America Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 10 North America Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 11 North America Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 12 North America Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 13 U.S. Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 14 U.S. Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 15 U.S. Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 16 U.S. Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 17 Canada Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 18 Canada Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 19 Canada Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 20 Canada Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 21 Europe Enzyme Immunoassay Market, by Country, 2018-2030 (USD Million)
Table 22 Europe Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 23 Europe Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 24 Europe Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 25 Europe Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 26 UK Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 27 UK Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 28 UK Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 29 UK Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 30 Germany Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 31 Germany Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 32 Germnay Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 33 Germany Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 34 France Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 35 France Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 36 France Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 37 France Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 38 Italy Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 39 Italy Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 40 Italy Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 41 Italy Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 42 Spain Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 43 Spain Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 44 Spain Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 45 Spain Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 46 Denmark Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 47 Denmark Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 48 Denmark Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 49 Denmark Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 50 Sweden Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 51 Sweden Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 52 Sweden Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 53 Sweden Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 54 Norway Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 55 Norway Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 56 Norway Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 57 Norway Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 58 Asia-Pacific Enzyme Immunoassay Market, by Country, 2018-2030 (USD Million)
Table 59 Asia-Pacific Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 60 Asia-Pacific Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 61 Asia-Pacific Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 62 Asia-Pacific Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 63 Japan Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 64 Japan Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 65 Japan Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 66 Japan Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 67 China Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 68 China Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 69 China Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 70 China Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 71 India Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 72 India Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 73 India Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 74 India Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 75 Australia Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 76 Australia Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 77 Australia Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 78 Australia Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 79 Thailand Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 80 Thailand Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 81 Thailand Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 82 Thailand Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 83 South Korea Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 84 South Korea Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 85 South Korea Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 86 South Korea Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 87 Latin America Enzyme Immunoassay Market, by Country, 2018-2030 (USD Million)
Table 88 Latin America Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 89 Latin America Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 90 Latin America Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 91 Latin America Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 92 Brazil Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 93 Brazil Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 94 Brazil Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 95 Brazil Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 96 Mexico Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 97 Mexico Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 98 Mexico Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 99 Mexico Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 100 Argentina Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 101 Argentina Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 102 Argentina Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 103 Argentina Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 104 Middle East & Africa Enzyme Immunoassay Market, by Country, 2018-2030 (USD Million)
Table 105 Middle East & Africa Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 106 Middle East & Africa Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 107 Middle East & Africa Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 108 Middle East & Africa Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 109 South Africa Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 110 South Africa Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 111 South Africa Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 112 South Africa Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 113 Saudi Arabia Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 114 Saudi Arabia Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 115 Saudi Arabia Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 116 Saudi Arabia Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 117 UAE Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 118 UAE Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 119 UAE Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 120 UAE Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 121 Kuwait Enzyme Immunoassay Market, by Product, 2018-2030 (USD Million)
Table 122 Kuwait Enzyme Immunoassay Market, by Application, 2018-2030 (USD Million)
Table 123 Kuwait Enzyme Immunoassay Market, by Specimen, 2018-2030 (USD Million)
Table 124 Kuwait Enzyme Immunoassay Market, by End-use, 2018-2030 (USD Million)
Table 125 Participant's Overview
Table 126 Financial Performance
Table 127 Key Companies Undergoing Expansions
Table 128 Key Companies Undergoing Acquisitions
Table 129 Key Companies Undergoing Collaborations
Table 130 Key Companies Launching New Products
Table 131 Key Companies Undertaking Other Strategies
List of Figures
Figure 1 Enzyme Immunoassay Market Segmentation
Figure 2 Market Research Process
Figure 3 Data Triangulation Techniques
Figure 4 Primary Research Pattern
Figure 5 Market Research Approaches
Figure 6 Market Formulation & Validation
Figure 7 Market Outlook
Figure 8 Segment Snapshot
Figure 9 Competitive Landscape Snapshot
Figure 10 Parent Market Outlook
Figure 11 Enzyme Immunoassay Market Driver Analysis
Figure 12 Enzyme Immunoassay Market Restraint Analysis
Figure 13 Enzyme Immunoassay Market: Porter's Analysis
Figure 14 Enzyme Immunoassay Market: PESTEL Analysis
Figure 15 Enzyme Immunoassay Market: Product Outlook and Key Takeaways
Figure 16 Enzyme Immunoassay Market: Product Market Share Analysis, 2023-2030
Figure 17 Global Enzyme Immunoassay by Reagents & Kits Market, 2018-2030 (USD Million)
Figure 18 Global Enzyme Immunoassay by Analyzers/instruments Market, 2018-2030 (USD Million)
Figure 19 Global Enzyme Immunoassay by Software & Services Market, 2018-2030 (USD Million)
Figure 20 Enzyme Immunoassay Market: Application Outlook and Key Takeaways
Figure 21 Enzyme Immunoassay Market: Application Market Share Analysis, 2023-2030
Figure 22 Global Enzyme Immunoassay by Therapeutic Drug Monitoring Market, 2018-2030 (USD Million)
Figure 23 Global Enzyme Immunoassay by Oncology Market, 2018-2030 (USD Million)
Figure 24 Global Enzyme Immunoassay by Cardiology Market, 2018-2030 (USD Million)
Figure 25 Global Enzyme Immunoassay by Endocrinology Market, 2018-2030 (USD Million)
Figure 26 Global Enzyme Immunoassay by Infectious Disease Testing Market, 2018-2030 (USD Million)
Figure 27 Global Enzyme Immunoassay by Autoimmune Diseases Market, 2018-2030 (USD Million)
Figure 28 Global Enzyme Immunoassay by Others Market, 2018-2030 (USD Million)
Figure 29 Enzyme Immunoassay Market: Specimen Outlook and Key Takeaways
Figure 30 Enzyme Immunoassay Market: Specimen Market Share Analysis, 2023-2030
Figure 31 Global Enzyme Immunoassay by Blood Market, 2018-2030 (USD Million)
Figure 32 Global Enzyme Immunoassay by Saliva Market, 2018-2030 (USD Million)
Figure 33 Global Enzyme Immunoassay by Urine Market, 2018-2030 (USD Million)
Figure 34 Global Enzyme Immunoassay by Other Specimens Market, 2018-2030 (USD Million)
Figure 35 Enzyme Immunoassay Market: End-use Outlook and Key Takeaways
Figure 36 Enzyme Immunoassay Market: End-use Market Share Analysis, 2023-2030
Figure 37 Global Enzyme Immunoassay by Hospitals Market, 2018-2030 (USD Million)
Figure 38 Global Enzyme Immunoassay by Blood Banks Market, 2018-2030 (USD Million)
Figure 39 Global Enzyme Immunoassay by Clinical Laboratories Market, 2018-2030 (USD Million)
Figure 40 Global Enzyme Immunoassay by Pharmaceutical and Biotech Companies Market, 2018-2030 (USD Million)
Figure 41 Global Enzyme Immunoassay by Academic Research Centers Market, 2018-2030 (USD Million)
Figure 42 Global Enzyme Immunoassay by Others Market, 2018-2030 (USD Million)
Figure 43 Regional Marketplace: Key Takeaways
Figure 44 North America Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 45 U.S. Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 46 Canada Enzyme Immunoassay Market, 2018-2030 (USD Million)
Figure 47 Europe Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 48 UK Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 49 Germany Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 50 France Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 51 Italy Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 52 Spain Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 53 Denmark Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 54 Sweden Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 55 Norway Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 56 Asia-Pacific Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 57 Japan Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 58 China Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 59 India Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 60 Australia Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 61 Thailand Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 62 South Korea Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 63 Latin America Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 64 Brazil Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 65 Mexico Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 66 Argentina Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 67 MEA Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 68 South Africa Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 69 Saudi Arabia Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 70 UAE Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 71 Kuwait Enzyme Immunoassay Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 72 Key Company Categorization
Figure 73 Company Market Positioning
Figure 74 Market Participant Categorization
Figure 75 Strategy Framework

Companies Mentioned

  • Siemens Healthineers
  • Danaher Corporation (Beckman Coulter)
  • bioMérieux SA
  • Sysmex Corporation
  • QuidelOrtho Corporation.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Becton, Dickinson, and Company
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedMay 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 17.67 Billion
Forecasted Market Value ( USD ) by 2030 $ 22.42 Billion
Compound Annual Growth Rate3.9%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Global Immunoassay Market by Product (Analyzer, Consumables), Technology (Chemiluminescence Immunoassay, Enzyme-linked Immunosorbent Assay, Fluoroimmunoassay), Specimen, Indication, End User - Forecast 2024-2030 - Product Image

Global Immunoassay Market by Product (Analyzer, Consumables), Technology (Chemiluminescence Immunoassay, Enzyme-linked Immunosorbent Assay, Fluoroimmunoassay), Specimen, Indication, End User - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
Global Immunoassay Market Size, Share & Trends Analysis Report by Product (Reagent & Kits, Analyzers/Instruments), Technology (RIA, ELISA), Application, Specimen, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Immunoassay Market Size, Share & Trends Analysis Report by Product (Reagent & Kits, Analyzers/Instruments), Technology (RIA, ELISA), Application, Specimen, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 180 Pages
  • Global
From
Global Immunoassay Analyzers Market by Product (Chemiluminescence Immunoassay, Consumables & Accessories, Enzyme-linked Immunoassay), Application (Autoimmune Disease, Cardiology, Endocrinology) - Forecast 2024-2030 - Product Image

Global Immunoassay Analyzers Market by Product (Chemiluminescence Immunoassay, Consumables & Accessories, Enzyme-linked Immunoassay), Application (Autoimmune Disease, Cardiology, Endocrinology) - Forecast 2024-2030

  • Report
  • 197 Pages
  • Global
From
Automated Immunoassay Analyzers - Global Strategic Business Report - Product Image

Automated Immunoassay Analyzers - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Immunoassay - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Immunoassay - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From

About the Enzyme Immunoassay Market

The Enzyme Immunoassay (EIA) market is a subset of the In Vitro Diagnostics (IVD) field, which encompasses a wide range of laboratory-based tests used to detect and quantify substances such as proteins, hormones, and antibodies in blood or other biological samples. EIAs, also known as enzyme-linked immunosorbent assays (ELISAs), utilize enzyme-labeled antibodies or antigens to produce a detectable signal, which is proportional to the amount of target analyte present in the sample. This technology is widely employed in clinical laboratories for its specificity and sensitivity in disease diagnosis, monitoring of therapy, and ensuring blood safety. EIAs are also used in food safety testing and research applications. Advancements in automation, monoclonal antibody technology, and the introduction of multiplex assays have expanded the capabilities and applications of EIAs in the IVD industry. In the Enzyme Immunoassay market, several key players provide a spectrum of EIA reagents, kits, and instrumentation. Prominent entities include Abbott Laboratories, Bio-Rad Laboratories, and Siemens Healthineers, all of which have a strong presence in IVD technologies. Other notable companies are Ortho Clinical Diagnostics, Roche Diagnostics, and Danaher Corporation, which operate under various brand names, offering a range of diagnostic solutions that cater to clinical and research needs across myriad health-related fields. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.